• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗原 Sm-p80:使用 TLR4 激动剂疫苗佐剂葡糖基脂质 A-明矾在小鼠和非人灵长类动物模型中的预防功效。

antigen Sm-p80: prophylactic efficacy using TLR4 agonist vaccine adjuvant glucopyranosyl lipid A-Alum in murine and non-human primate models.

机构信息

Center for Tropical Medicine and Infectious Diseases, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.

Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.

出版信息

J Investig Med. 2018 Dec;66(8):1124-1132. doi: 10.1136/jim-2018-000786. Epub 2018 Jul 10.

DOI:10.1136/jim-2018-000786
PMID:29997146
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6288690/
Abstract

Sm-p80, the large subunit of calpain, is a leading candidate for a schistosomiasis vaccine. The prophylactic and antifecundity efficacy of Sm-p80 has been tested in three animal models (mouse, hamster and baboon) using a multitude of vaccine formulations and approaches. In our continual effort to enhance the vaccine efficacy, in this study, we have utilized the adjuvant, synthetic hexa-acylated lipid A derivative, glucopyranosyl lipid A (GLA) formulated in aluminum (GLA-Alum) with recombinant Sm-p80. The rSm-p80+GLA-Alum immunization regimen provided 33.33%-53.13% reduction in worm burden in the mouse model and 38% worm burden reduction in vaccinated baboons. Robust Sm-p80-specific immunoglobulin (Ig)G, IgG1, IgG2a and IgM responses were observed in all immunized animals. The rSm-p80+GLA-Alum coadministration induced a mix of T-helper (Th) cells (Th1, Th2 and Th17) responses as determined via the release of interleukin (IL)-2, IL-4, IL-18, IL-21, IL-22 and interferon-γ.

摘要

Sm-p80 是钙蛋白酶的大亚基,是血吸虫病疫苗的主要候选者。Sm-p80 的预防性和抗生育功效已在三种动物模型(小鼠、仓鼠和狒狒)中使用多种疫苗制剂和方法进行了测试。为了提高疫苗的疗效,在这项研究中,我们使用了佐剂、合成六酰化脂 A 衍生物葡糖基脂质 A(GLA)与重组 Sm-p80 一起用铝(GLA-Alum)配制。rSm-p80+GLA-Alum 免疫方案使小鼠模型中的虫荷减少了 33.33%-53.13%,接种疫苗的狒狒中的虫荷减少了 38%。所有免疫动物均观察到强烈的 Sm-p80 特异性免疫球蛋白(Ig)G、IgG1、IgG2a 和 IgM 反应。rSm-p80+GLA-Alum 共同给药诱导了辅助性 T 细胞(Th)细胞(Th1、Th2 和 Th17)反应的混合,这是通过释放白细胞介素(IL)-2、IL-4、IL-18、IL-21、IL-22 和干扰素-γ来确定的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db9e/6288690/2f89496150b4/jim-2018-000786f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db9e/6288690/f056ba272012/jim-2018-000786f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db9e/6288690/05a2d57f1837/jim-2018-000786f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db9e/6288690/0b1c71455be9/jim-2018-000786f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db9e/6288690/2f89496150b4/jim-2018-000786f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db9e/6288690/f056ba272012/jim-2018-000786f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db9e/6288690/05a2d57f1837/jim-2018-000786f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db9e/6288690/0b1c71455be9/jim-2018-000786f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db9e/6288690/2f89496150b4/jim-2018-000786f04.jpg

相似文献

1
antigen Sm-p80: prophylactic efficacy using TLR4 agonist vaccine adjuvant glucopyranosyl lipid A-Alum in murine and non-human primate models.抗原 Sm-p80:使用 TLR4 激动剂疫苗佐剂葡糖基脂质 A-明矾在小鼠和非人灵长类动物模型中的预防功效。
J Investig Med. 2018 Dec;66(8):1124-1132. doi: 10.1136/jim-2018-000786. Epub 2018 Jul 10.
2
Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine.基于 Sm-p80 的 DNA 疫苗为狒狒提供了针对曼氏血吸虫感染的保护水平,可与辐照尾蚴疫苗相当。
J Infect Dis. 2010 Apr 1;201(7):1105-12. doi: 10.1086/651147.
3
Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons.种间保护:曼氏血吸虫 Sm-p80 疫苗可预防仓鼠和狒狒感染埃及血吸虫。
Vaccine. 2014 Mar 5;32(11):1296-303. doi: 10.1016/j.vaccine.2013.12.057. Epub 2014 Jan 4.
4
Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium.基于曼氏血吸虫、日本血吸虫和埃及血吸虫发育过程中Sm-p80疫苗的跨物种预防效果及Sm-p80/Sm-p80直系同源蛋白的细胞内定位
Parasitol Res. 2017 Nov;116(11):3175-3188. doi: 10.1007/s00436-017-5634-4. Epub 2017 Oct 12.
5
Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic.在曼氏血吸虫感染的非人灵长类动物模型中进行 Sm-p80 疫苗的临床前预防功效测试,以及在流行血吸虫病的地区从人体血清样本中检测到 Sm-p80 的免疫球蛋白 G 和 E 反应。
J Infect Dis. 2011 Nov;204(9):1437-49. doi: 10.1093/infdis/jir545. Epub 2011 Sep 15.
6
Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model.基于Sm-p80的DNA疫苗制剂在非人灵长类动物模型中对曼氏血吸虫的保护和抗生育作用。
Vaccine. 2009 May 11;27(21):2830-7. doi: 10.1016/j.vaccine.2009.02.096. Epub 2009 Mar 10.
7
Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice.Sm-p80 与瑞喹莫德联合佐剂对曼氏血吸虫感染小鼠的保护作用。
Int J Infect Dis. 2010 Sep;14(9):e781-7. doi: 10.1016/j.ijid.2010.02.2266. Epub 2010 Jul 13.
8
Sm-p80-based schistosomiasis vaccine mediated epistatic interactions identified potential immune signatures for vaccine efficacy in mice and baboons.基于Sm-p80的血吸虫病疫苗介导的上位性相互作用确定了小鼠和狒狒疫苗效力的潜在免疫特征。
PLoS One. 2017 Feb 13;12(2):e0171677. doi: 10.1371/journal.pone.0171677. eCollection 2017.
9
Schistosoma mansoni antigen Sm-p80: Prophylactic efficacy of a vaccine formulated in human approved plasmid vector and adjuvant (VR 1020 and alum).曼氏血吸虫抗原 Sm-p80:在人用批准质粒载体和佐剂(VR 1020 和明矾)中配制的疫苗的预防功效。
Acta Trop. 2011 May;118(2):142-51. doi: 10.1016/j.actatropica.2011.01.010. Epub 2011 Feb 18.
10
Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons.利用基于 Sm-p80 的治疗性疫苗杀死慢性感染狒狒体内已建立的成年血吸虫寄生虫。
J Infect Dis. 2014 Jun 15;209(12):1929-40. doi: 10.1093/infdis/jiu031. Epub 2014 Jan 16.

引用本文的文献

1
Pre-clinical studies of Schistosoma mansoni vaccines: A scoping review.曼氏血吸虫疫苗的临床前研究:一项范围综述。
PLoS Negl Trop Dis. 2025 Jun 2;19(6):e0012956. doi: 10.1371/journal.pntd.0012956. eCollection 2025 Jun.
2
Application of microphysiological systems to unravel the mechanisms of schistosomiasis egg extravasation.应用微生理系统揭示血吸虫虫卵外渗的机制。
Front Cell Infect Microbiol. 2025 Feb 18;15:1521265. doi: 10.3389/fcimb.2025.1521265. eCollection 2025.
3
Transmission-Blocking Vaccines against Schistosomiasis Japonica.

本文引用的文献

1
Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium.基于曼氏血吸虫、日本血吸虫和埃及血吸虫发育过程中Sm-p80疫苗的跨物种预防效果及Sm-p80/Sm-p80直系同源蛋白的细胞内定位
Parasitol Res. 2017 Nov;116(11):3175-3188. doi: 10.1007/s00436-017-5634-4. Epub 2017 Oct 12.
2
Sm-p80-Based Schistosomiasis Vaccine: Preparation for Human Clinical Trials.基于Sm-p80的血吸虫病疫苗:人类临床试验准备
Trends Parasitol. 2017 Mar;33(3):194-201. doi: 10.1016/j.pt.2016.10.010. Epub 2016 Nov 16.
3
日本血吸虫病传播阻断疫苗。
Int J Mol Sci. 2024 Jan 30;25(3):1707. doi: 10.3390/ijms25031707.
4
A Critical Review on Human Malaria and Schistosomiasis Vaccines: Current State, Recent Advancements, and Developments.关于人类疟疾和血吸虫病疫苗的批判性综述:现状、最新进展与发展
Vaccines (Basel). 2023 Apr 4;11(4):792. doi: 10.3390/vaccines11040792.
5
Anti-schistosomal immunity to core xylose/fucose in N-glycans.针对N-聚糖中核心木糖/岩藻糖的抗血吸虫免疫。
Front Mol Biosci. 2023 Apr 4;10:1142620. doi: 10.3389/fmolb.2023.1142620. eCollection 2023.
6
Human Schistosomiasis Vaccines as Next Generation Control Tools.作为下一代控制工具的人类血吸虫病疫苗
Trop Med Infect Dis. 2023 Mar 14;8(3):170. doi: 10.3390/tropicalmed8030170.
7
Pattern recognition receptor signaling and innate immune responses to schistosome infection.模式识别受体信号转导与血吸虫感染的固有免疫应答。
Front Cell Infect Microbiol. 2022 Oct 21;12:1040270. doi: 10.3389/fcimb.2022.1040270. eCollection 2022.
8
De Novo Design of Cathepsin B1 Inhibitors as Potential Anti-Schistosomal Agents Using Computational Studies.利用计算研究从头设计组织蛋白酶B1抑制剂作为潜在的抗血吸虫病药物
Adv Appl Bioinform Chem. 2022 Aug 1;15:29-41. doi: 10.2147/AABC.S361626. eCollection 2022.
9
Vaccines for Human Schistosomiasis: Recent Progress, New Developments and Future Prospects.人类血吸虫病疫苗:最新进展、新发展和未来展望。
Int J Mol Sci. 2022 Feb 18;23(4):2255. doi: 10.3390/ijms23042255.
10
A comprehensive and critical overview of schistosomiasis vaccine candidates.血吸虫病候选疫苗的全面批判性综述。
J Parasit Dis. 2021 Jun;45(2):557-580. doi: 10.1007/s12639-021-01387-w. Epub 2021 Apr 25.
A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasis.
一种由曼氏血吸虫组织蛋白酶B与Montanide ISA 720 VG混合配制而成的疫苗可诱导产生针对小鼠血吸虫病的高水平保护作用。
BMC Infect Dis. 2016 Mar 5;16:112. doi: 10.1186/s12879-016-1444-z.
4
Do schistosome vaccine trials in mice have an intrinsic flaw that generates spurious protection data?小鼠血吸虫疫苗试验是否存在产生虚假保护数据的内在缺陷?
Parasit Vectors. 2016 Feb 17;9:89. doi: 10.1186/s13071-016-1369-9.
5
Workshop report: Schistosomiasis vaccine clinical development and product characteristics.研讨会报告:血吸虫病疫苗的临床开发及产品特性
Vaccine. 2016 Feb 17;34(8):995-1001. doi: 10.1016/j.vaccine.2015.12.032. Epub 2015 Dec 22.
6
Evidence That Rhesus Macaques Self-Cure from a Schistosoma japonicum Infection by Disrupting Worm Esophageal Function: A New Route to an Effective Vaccine?恒河猴通过破坏蠕虫食管功能自我治愈日本血吸虫感染的证据:一种有效的疫苗新途径?
PLoS Negl Trop Dis. 2015 Jul 10;9(7):e0003925. doi: 10.1371/journal.pntd.0003925. eCollection 2015.
7
Longevity of Sm-p80-specific antibody responses following vaccination with Sm-p80 vaccine in mice and baboons and transplacental transfer of Sm-p80-specific antibodies in a baboon.在小鼠和狒狒中用Sm-p80疫苗接种后Sm-p80特异性抗体反应的持久性以及一只狒狒中Sm-p80特异性抗体的胎盘转移。
Parasitol Res. 2014 Jun;113(6):2239-50. doi: 10.1007/s00436-014-3879-8. Epub 2014 Apr 12.
8
Human schistosomiasis.人体血吸虫病。
Lancet. 2014 Jun 28;383(9936):2253-64. doi: 10.1016/S0140-6736(13)61949-2. Epub 2014 Apr 1.
9
Schistosomiasis.血吸虫病
Curr Protoc Immunol. 2013 Nov 18;103:19.1.1-19.1.58. doi: 10.1002/0471142735.im1901s103.
10
Simultaneous priming with DNA encoding Sm-p80 and boosting with Sm-p80 protein confers protection against challenge infection with Schistosoma mansoni in mice.同时用编码 Sm-p80 的 DNA 进行初始免疫和用 Sm-p80 蛋白进行加强免疫可在小鼠中预防曼氏血吸虫感染。
Parasitol Res. 2014 Mar;113(3):1195-200. doi: 10.1007/s00436-014-3757-4. Epub 2014 Jan 23.